Gao et al. demonstrated CAR-T cells targeting GPC3, a heparan sulfate proteoglycan which is not expressed in normal liver but overexpressed in HCC, effectively eliminating the growth of HCC in in vitro and in vivo [84]. Here, CD44 is linked to hepatocellular carcinoma.